review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Clare M Lloyd | |
P2860 | cites work | Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling | Q24654972 |
Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium | Q34202130 | ||
Mouse models of allergic airway disease | Q34212495 | ||
Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling | Q34749587 | ||
An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen | Q35532079 | ||
The relationship between asthma and COPD. Lessons from transgenic mice | Q35859719 | ||
Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling | Q36023612 | ||
Prolonged allergen challenge in mice leads to persistent airway remodelling. | Q36193173 | ||
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. | Q36209876 | ||
The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppres | Q36362328 | ||
The importance of leukotrienes in airway inflammation in a mouse model of asthma | Q36367477 | ||
Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma | Q36377337 | ||
Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness | Q36401550 | ||
Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction | Q37362201 | ||
Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes | Q37374777 | ||
GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice | Q37387760 | ||
Accumulation of Peribronchial Mast Cells in a Mouse Model of Ovalbumin Allergen Induced Chronic Airway Inflammation: Modulation by Immunostimulatory DNA Sequences | Q38348928 | ||
Inhibition of airway remodeling in IL-5-deficient mice | Q40553706 | ||
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production | Q40849898 | ||
A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model | Q43846995 | ||
The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma | Q43873557 | ||
Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation | Q44191932 | ||
Dissociation of T helper type 2 cytokine-dependent airway lesions from signal transducer and activator of transcription 6 signalling in experimental chronic asthma. | Q44444624 | ||
Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma | Q44444630 | ||
Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling | Q44641935 | ||
Effects of anticytokine therapy in a mouse model of chronic asthma | Q45015140 | ||
Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism | Q45140673 | ||
House dust mite facilitates ovalbumin-specific allergic sensitization and airway inflammation | Q47800595 | ||
Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma. | Q47895692 | ||
A critical role for eosinophils in allergic airways remodeling | Q47925478 | ||
Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. | Q51636510 | ||
Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice | Q53779386 | ||
Involvement of distal airways in a chronic model of experimental asthma | Q58131140 | ||
Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells | Q59310681 | ||
Mouse model of airway remodeling: strain differences | Q73663337 | ||
Regulation of antigen-specific IgE, IgG1, and mast cell responses to ingested allergen by mucosal tolerance induction | Q73705708 | ||
Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma | Q74417771 | ||
Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet | Q77476285 | ||
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway | Q81672236 | ||
P433 | issue | 3 | |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 231-236 | |
P577 | publication date | 2007-06-01 | |
P1433 | published in | Current Allergy and Asthma Reports | Q2246111 |
P1476 | title | Building better mouse models of asthma | |
P478 | volume | 7 |
Q34114469 | Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice |
Q44390096 | Animal models of asthma: utility and limitations |
Q47233399 | Anti-inflammatory effects of embelin in A549 cells and human asthmatic airway epithelial tissues |
Q51070419 | Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma. |
Q37085763 | Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma |
Q51703541 | General and Specific Mouse Models for Asthma Research. |
Q37596511 | In utero exposure to second-hand smoke aggravates the response to ovalbumin in adult mice |
Q36333118 | In vitro measurements of tracheal constriction using mice |
Q57093925 | Influenza in Asthmatics: For Better or for Worse? |
Q34621642 | Key mediators in the immunopathogenesis of allergic asthma |
Q49877418 | Lessons from ten years of genome-wide association studies of asthma |
Q49928696 | Modeling asthma: Pitfalls, promises, and the road ahead |
Q37353895 | Mouse models of allergic asthma: acute and chronic allergen challenge |
Q37026629 | Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity |
Q36064548 | Regulatory T cells in asthma |
Q35121554 | Rhinovirus exacerbates house-dust-mite induced lung disease in adult mice |
Q41457326 | Suppression of OVA-alum induced allergy by Heligmosomoides polygyrus products is MyD88-, TRIF-, regulatory T- and B cell-independent, but is associated with reduced innate lymphoid cell activation. |
Q84290562 | [Again an asthma model... but a useful one] |
Search more.